Human leukocyte antigen (HLA) matching improves survival after kidney transplantation, but it is not known whether matching affects outcomes after liver transplantation. Balan et al. used data ...

Garuda Therapeutics (Garuda), a biotechnology company creating off-the-shelf, HSC therapies for a multitude of blood disorders, today announced the successful completion of an approximately $50 ...

Early approaches focused on the importance of HLA matching, and were an important aspect of deceased organ donor allocation. More recently, and as a direct result of improvements in ...

Two questions directly pertain to the feasibility of such an approach: first, how many such cell lines would be needed for HLA matching to the majority of iPS cell recipients, and second ...

To help lower the risk of organ rejection, it is crucial to find as close an HLA match between the donor and recipient as possible. While HLA typing has been around for decades, more recent ...

European regulators have cleared Anocca to begin a Phase I/II umbrella trial of its lead targeted T-cell receptor (TCR) therapy ANOC-001 and other pipeline candidates in certain advanced pancreatic ...

Further on February 24 to 28 this year, 15 laboratory personnel were trained on HLA testing and gaining hands-on experience with the newly acquired equipment ...